Analyze Diet
The Veterinary record1987; 120(23); 548-552; doi: 10.1136/vr.120.23.548

Clinical observations on the use of BCG cell wall fraction for treatment of periocular and other equine sarcoids.

Abstract: Clinical observations on the use of BCG cell wall fraction in oil for treating seven horses with periocular sarcoids and five horses with sarcoids in other regions are described. Therapy was successful when used for periocular or solitary and smaller sarcoids. For sarcoids previously treated with cryosurgery, therapy appeared to be less efficient. A horse with a sarcoid on the stifle developed a septic gonitis due to necrosis of the sarcoid tissue adjacent to the joint. Sarcoids of the axilla appeared to be more aggressive than sarcoids at other locations and did not respond favourably to this form of therapy.
Publication Date: 1987-06-06 PubMed ID: 3303640DOI: 10.1136/vr.120.23.548Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper investigates the effects of BCG cell wall fraction treatment on sarcoids (a type of skin tumor) in horses. The authors find that the treatment is generally successful for smaller, isolated, and near-eye tumors but may have limitations in other situations.

Objective of the Research

  • The goal of this clinical research was to assess the efficiency of a therapy using BCG cell wall fraction in oil to treat sarcoids—a kind of skin tumour—emerging on horses. The therapy was applied on seven horses having periocular (around the eye) sarcoids and five horses with sarcoids in other areas.

Main Findings

  • The therapy was successful in treating periocular sarcoids or single, smaller sarcoids. It indicates that the BCG cell wall fraction treatment can be effective for treating certain types of sarcoids, particularly those that are small and isolated, or those located near the eyes.
  • The treatment was less effective for sarcoids that had been previously treated with cryosurgery. Cryosurgery is a method that uses extreme cold to destroy abnormal tissue. The reduced efficacy of the BCG cell wall fraction treatment in these cases might originate from the prior use of cryosurgery, suggesting that the two forms of treatment may not work well together.
  • One horse with a sarcoid on the stifle (an area on the hind leg) developed a septic gonitis—a condition involving inflammation of a joint—because of the necrosis (cell death) of the sarcoid tissue near the joint. This could mean the therapy may induce complications when applied to sarcoids near joints.
  • Sarcoids located in the axilla (underarm area) of horses appeared to be more aggressive than those found elsewhere and did not respond positively to the BCG cell wall fraction treatment. It implies that the therapy might not be suitable for treating more aggressive forms of sarcoids or those located in specific areas like the axilla.

Implications of the Study

  • This study provided valuable insights into the effectiveness and limitations of BCG cell wall fraction treatment in addressing equine sarcoids. By identifying factors that may affect response to the therapy, such as tumor size, location, previous treatments, and nature of the sarcoids, the study can contribute to improving treatment strategies for equine sarcoids in the future.

Cite This Article

APA
Owen RA, Jagger DW. (1987). Clinical observations on the use of BCG cell wall fraction for treatment of periocular and other equine sarcoids. Vet Rec, 120(23), 548-552. https://doi.org/10.1136/vr.120.23.548

Publication

ISSN: 0042-4900
NlmUniqueID: 0031164
Country: England
Language: English
Volume: 120
Issue: 23
Pages: 548-552

Researcher Affiliations

Owen, R A
    Jagger, D W

      MeSH Terms

      • Animals
      • BCG Vaccine / therapeutic use
      • Cell Wall / immunology
      • Eyelid Diseases / therapy
      • Eyelid Diseases / veterinary
      • Horse Diseases / therapy
      • Horses
      • Mycobacterium bovis / immunology
      • Mycobacterium bovis / ultrastructure
      • Sarcoidosis / therapy
      • Sarcoidosis / veterinary

      Citations

      This article has been cited 4 times.
      1. Jindra C, Hainisch EK, Brandt S. Immunotherapy of Equine Sarcoids-From Early Approaches to Innovative Vaccines. Vaccines (Basel) 2023 Mar 30;11(4).
        doi: 10.3390/vaccines11040769pubmed: 37112681google scholar: lookup
      2. Nappert G, Lavoie JP, Sauvageau R, Scott DW. Le sarcoïde équin: présentation d'un cas clinique. Can Vet J 1989 Nov;30(11):897-9.
        pubmed: 17423459
      3. Carstanjen B, Jordan P, Lepage OM. Carbon dioxide laser as a surgical instrument for sarcoid therapy--a retrospective study on 60 cases. Can Vet J 1997 Dec;38(12):773-6.
        pubmed: 9426943
      4. Rutten VP, Klein WR, De Jong WA, Misdorp W, Steerenberg PA, De Jong WH, Den Otter W, Ruitenberg EJ. Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls. Cancer Immunol Immunother 1991;34(3):186-90.
        doi: 10.1007/BF01742311pubmed: 1756535google scholar: lookup